Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$15.67
+1.6%		$15.19
$9.39
▼
$16.29
$637.34M0.33382,082 shs439,368 shs
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$9.93
+21.9%		$8.02
$1.87
▼
$10.05
$2.17B2.084.25 million shs19.72 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$659.32
+0.1%		$597.90
$435.27
▼
$663.57
$243.57B0.851.98 million shs2.10 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$371.58
+2.7%		$349.39
$223.83
▼
$386.00
$25.46B1.14531,539 shs730,810 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
+1.62%-0.06%-0.51%+21.06%+46.04%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
+21.94%+27.70%+4.48%+28.94%+354.28%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-0.02%+2.88%+4.82%+33.91%+38.94%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+2.73%+1.98%+5.28%+8.80%+47.31%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$15.67
+1.6%		$15.19
$9.39
▼
$16.29
$637.34M0.33382,082 shs439,368 shs
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$9.93
+21.9%		$8.02
$1.87
▼
$10.05
$2.17B2.084.25 million shs19.72 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$659.32
+0.1%		$597.90
$435.27
▼
$663.57
$243.57B0.851.98 million shs2.10 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$371.58
+2.7%		$349.39
$223.83
▼
$386.00
$25.46B1.14531,539 shs730,810 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
+1.62%-0.06%-0.51%+21.06%+46.04%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
+21.94%+27.70%+4.48%+28.94%+354.28%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-0.02%+2.88%+4.82%+33.91%+38.94%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+2.73%+1.98%+5.28%+8.80%+47.31%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
2.40
Hold$19.5024.44% Upside
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.50
Moderate Buy$7.25-26.96% Downside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.73
Moderate Buy$624.64-5.26% Downside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.86
Moderate Buy$382.002.80% Upside

Current Analyst Ratings Breakdown

Latest ANGO, TMO, WST, and BFLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/22/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$10.00
9/22/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$365.00 ➝ $400.00
9/11/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$10.00
9/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold ➝ Overweight
9/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Scotiabank logo
Scotiabank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform
9/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeMarket Perform
9/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweight ➝ Underweight
9/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Underperform
9/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
9/9/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$340.00 ➝ $415.00
9/8/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Buy$540.00 ➝ $730.00
(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$320.17M2.02$0.32 per share49.29$4.13 per share3.79
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$97.61M27.08N/AN/A$0.77 per share12.89
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$44.56B5.47$30.43 per share21.67$142.17 per share4.64
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$3.07B8.51$10.00 per share37.15$44.10 per share8.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$36.74M-$0.87N/AN/AN/A-11.48%-5.73%-3.77%10/1/2026 (Estimated)
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$77.06M-$0.29N/AN/AN/A-66.74%-33.99%-22.96%10/30/2026 (Estimated)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.70B$18.5935.4723.972.7615.04%17.09%8.12%10/28/2026 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$493.70M$7.8147.5837.572.5316.98%20.11%14.83%10/22/2026 (Estimated)

Latest ANGO, TMO, WST, and BFLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/1/2026Q1 2027
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.1125N/AN/AN/A$80.51 millionN/A
7/30/2026Q2 2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.0350-$0.01+$0.0250-$0.05$29.16 million$32.61 million
7/23/2026Q2 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.71$6.03+$0.32$4.68$11.71 billion$11.99 billion
7/23/2026Q2 2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.08$2.37+$0.29$2.15$839.98 million$872.30 million
7/14/2026Q4 2026
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.11-$0.07+$0.04-$0.27$80.24 million$86.61 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.880.29%+14.34%10.11%8 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.880.24%+5.51%11.27%N/A

Latest ANGO, TMO, WST, and BFLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.29%9/15/20269/15/202610/15/2026
7/21/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.220.26%7/29/20267/29/20268/5/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
2.19
1.49
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
4.06
3.06
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.74
1.55
1.18
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.82
2.12

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
6.00%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
21.99%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
63241.33 million38.85 millionOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
220266.29 million207.73 millionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000369.75 million368.53 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,80070.38 million69.95 millionOptionable

Recent News About These Companies

State Street Corp Acquires 54,920 Shares of West Pharmaceutical Services, Inc. $WST
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-state-street-corp-acquires-54920-shares-of-west-pharmaceutical-services-inc-wst-2026-09-23/
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says
September 22 at 1:03 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/west-pharmaceutical-poised-see-eps-150741335.html
Nykredit A S Takes $8.78 Million Position in West Pharmaceutical Services, Inc. $WST
September 21 at 3:29 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nykredit-a-s-takes-878-million-position-in-west-pharmaceutical-services-inc-wst-2026-09-21/
Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)
September 20 at 7:04 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/layoffs-cyber-disruptions-annex-1-191033936.html
What Is Drawing Attention To West Pharmaceutical Services (WST)?
September 20 at 2:04 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/drawing-attention-west-pharmaceutical-services-140744151.html
Bank of America Corp DE Invests $125.82 Million in West Pharmaceutical Services, Inc. $WST
September 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-invests-12582-million-in-west-pharmaceutical-services-inc-wst-2026-09-19/
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
September 18, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2991895/reasons-to-add-west-pharmaceutical-stock-to-your-portfolio-now?cid=cs-stocknewsapi-ft-analyst_blog|rank_focused-2991895
Is West Pharmaceutical Services Stock Outperforming the Nasdaq?
September 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/west-pharmaceutical-services-stock-outperforming-115008400.html
Annette Favorite Sells 2,500 Shares of West Pharmaceutical Services (NYSE:WST) Stock
September 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31029275
Annette Favorite Sells 2,524 Shares of West Pharmaceutical Services (NYSE:WST) Stock
September 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31029286
West Pharmaceutical Services, Inc. $WST Shares Sold by Squarepoint Ops LLC
September 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-west-pharmaceutical-services-inc-wst-shares-sold-by-squarepoint-ops-llc-2026-09-17/
Is West Pharmaceutical Services Stock Outperforming the Nasdaq?
September 16, 2026  |  barchart.comhttps://www.barchart.com/story/news/4631347/is-west-pharmaceutical-services-stock-outperforming-the-nasdaq
West Pharmaceutical Services (NYSE:WST) VP Sells 2,500 Shares
September 16, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-wst-insider-buying-and-selling-2026-09-16/
Insider Selling: West Pharmaceutical Services (NYSE:WST) VP Sells 2,500 Shares
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-west-pharmaceutical-services-nyse-wst-vp-sells-2500-shares-2026-09-15/
West Pharmaceutical Services (NYSE:WST) VP Sells 2,500 Shares of Stock
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-west-pharmaceutical-services-nyse-wst-vp-sells-2500-shares-of-stock-2026-09-15/
Insider Selling: West Pharmaceutical Services (NYSE:WST) VP Sells $921,260.00 in Stock
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-west-pharmaceutical-services-nyse-wst-vp-sells-92126000-in-stock-2026-09-15/
West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946032-west-pharmaceutical-services-inc-wst-presents-at-morgan-stanley-24th-annual-global-healthcare
WINTON GROUP Ltd Sells 30,711 Shares of West Pharmaceutical Services, Inc. $WST
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-winton-group-ltd-sells-30711-shares-of-west-pharmaceutical-services-inc-wst-2026-09-14/
West Pharmaceutical Services, Inc. $WST Shares Acquired by Corient Private Wealth LP
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-west-pharmaceutical-services-inc-wst-shares-acquired-by-corient-private-wealth-lp-2026-09-14/
National Pension Service Has $45.33 Million Holdings in West Pharmaceutical Services, Inc. $WST
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-national-pension-service-has-4533-million-holdings-in-west-pharmaceutical-services-inc-wst-2026-09-13/
Baird Financial Group Inc. Sells 10,379 Shares of West Pharmaceutical Services, Inc. $WST
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-baird-financial-group-inc-sells-10379-shares-of-west-pharmaceutical-services-inc-wst-2026-09-13/

New MarketBeat Followers Over Time

Media Sentiment Over Time

AngioDynamics stock logo

AngioDynamics NASDAQ:ANGO

$15.67 +0.25 (+1.62%)
Closing price 09/22/2026 04:00 PM Eastern
Extended Trading
$15.67 0.00 (0.00%)
As of 09/22/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$9.93 +1.79 (+21.94%)
Closing price 09/22/2026 03:59 PM Eastern
Extended Trading
$9.88 -0.05 (-0.51%)
As of 09/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$659.32 +0.56 (+0.09%)
Closing price 09/22/2026 03:59 PM Eastern
Extended Trading
$658.12 -1.20 (-0.18%)
As of 09/22/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$371.58 +9.80 (+2.71%)
Closing price 09/22/2026 03:59 PM Eastern
Extended Trading
$371.15 -0.43 (-0.12%)
As of 09/22/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas